547 related articles for article (PubMed ID: 26598975)
21. Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity.
Zhu K; Shao J; Tao H; Yan X; Luo C; Zhang H; Duan W
J Comput Aided Mol Des; 2019 Aug; 33(8):775-785. PubMed ID: 31312965
[TBL] [Abstract][Full Text] [Related]
22. Activity-based protein profiling of protein arginine methyltransferase 1.
Obianyo O; Causey CP; Jones JE; Thompson PR
ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
[TBL] [Abstract][Full Text] [Related]
23. A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes.
Iyamu ID; Al-Hamashi AA; Huang R
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34201091
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
[TBL] [Abstract][Full Text] [Related]
25. Peptidic transition state analogues as PRMT inhibitors.
Zhang Y; van Haren MJ; Martin NI
Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
[TBL] [Abstract][Full Text] [Related]
26. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
27. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
[TBL] [Abstract][Full Text] [Related]
28. A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).
Kaniskan HÜ; Szewczyk MM; Yu Z; Eram MS; Yang X; Schmidt K; Luo X; Dai M; He F; Zang I; Lin Y; Kennedy S; Li F; Dobrovetsky E; Dong A; Smil D; Min SJ; Landon M; Lin-Jones J; Huang XP; Roth BL; Schapira M; Atadja P; Barsyte-Lovejoy D; Arrowsmith CH; Brown PJ; Zhao K; Jin J; Vedadi M
Angew Chem Int Ed Engl; 2015 Apr; 54(17):5166-70. PubMed ID: 25728001
[TBL] [Abstract][Full Text] [Related]
29. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
Gao Y; Feng C; Ma J; Yan Q
Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
[TBL] [Abstract][Full Text] [Related]
31. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
32. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
[TBL] [Abstract][Full Text] [Related]
33. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
[TBL] [Abstract][Full Text] [Related]
34. Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
Zhang WY; Lu WC; Jiang H; Lv ZB; Xie YQ; Lian FL; Liang ZJ; Jiang YX; Wang DJ; Luo C; Jin J; Ye F
Chem Biol Drug Des; 2017 Dec; 90(6):1260-1270. PubMed ID: 28636189
[TBL] [Abstract][Full Text] [Related]
35. Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine.
Li Y; Zhu R; Wang W; Fu D; Hou J; Ji S; Chen B; Hu Z; Shao X; Yu X; Zhao Q; Zhang B; Du C; Bu Q; Hu C; Tang Y; Zhong L; Yang S; Zhao Y; Cen X
J Neurosci; 2015 Sep; 35(37):12890-902. PubMed ID: 26377474
[TBL] [Abstract][Full Text] [Related]
36. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
Yoshimatsu M; Toyokawa G; Hayami S; Unoki M; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):562-73. PubMed ID: 20473859
[TBL] [Abstract][Full Text] [Related]
38. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
39. Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level.
Tewary SK; Zheng YG; Ho MC
Cell Mol Life Sci; 2019 Aug; 76(15):2917-2932. PubMed ID: 31123777
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.
Wang J; Chen L; Sinha SH; Liang Z; Chai H; Muniyan S; Chou YW; Yang C; Yan L; Feng Y; Li KK; Lin MF; Jiang H; Zheng YG; Luo C
J Med Chem; 2012 Sep; 55(18):7978-87. PubMed ID: 22928876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]